医护人员中疫苗接种与混合免疫对奥密克戎变异株感染的保护作用比较
该回顾性研究纳入Laiko大学医院1305名已接种疫苗的医护人员,比较混合免疫(感染后接种疫苗)与仅接种疫苗对奥密克戎感染的保护效果。混合免疫组再感染率9.6%,全程接种组感染率46.1%(13.4/100人月),加强接种组44.1%(12.2/100人月)。混合免疫的保护作用约为全程或加强接种的5倍。
要点
- 混合免疫组再感染率9.6%,全程接种组感染率46.1%,加强接种组44.1%。
- 混合免疫对奥密克戎感染的保护作用约为全程或加强接种的5倍。
- 未发现性别或年龄与新冠感染的关联,无重症或死亡。
核心结论
- 在暴露风险高的医护人员中,混合免疫对奥密克戎变异株感染的保护作用约为全程或加强接种的5倍。
研究设计与样本
- 回顾性收集2020年12月29日至2022年5月24日Laiko大学医院所有医护人员定期主动PCR检测数据。
- 分析纳入1305名已接种疫苗的医护人员,中位年龄47岁(IQR:36,56),女性占66.7%。
- 感染率计算自2021年12月21日奥密克戎成为希腊主要流行变异株后,以总感染数(PCR阳性 regardless of symptoms)除以总人月风险。
主要发现
- 135名参与者在奥密克戎流行前感染过新冠,其中仅13人(9.6%)再感染。
- 全程接种组154人中71人感染(46.1%,感染率13.4/100人月),加强接种组1016人中448人感染(44.1%,感染率12.2/100人月)。
- 未发现性别或年龄与新冠感染的关联,无参与者出现重症或死亡。
临床怎么用
- 作者认为,该结果可能为公共卫生政策提供信息,以优化疫苗接种时机和方式以达到最佳免疫。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AIM: The Omicron COVID-19 variants BA.1* and BA.2* evade immune system leading to increased transmissibility and breakthrough infections. We aim to test the hypothesis that immunity achieved post COVID-19 infection combined with vaccination (hybrid immunity), is more effective against Omicron infection than vaccination alone in a health-care setting. METHODS: Data on regular pre-emptive PCR testing from all Health-Care Workers (HCWs) at Laiko University Hospital from 29th December 2020, date on which the national COVID-19 immunization program began in Greece, until 24th May 2022, were retrospectively collected and recorded. The infection rate was calculated after December 21st, 2021, when Omicron was the predominant circulating variant in Greece, as the total number of infections (positive PCR COVID-19 test regardless of symptoms) divided by the total person-months at risk. RESULTS: Of 1,305 vaccinated HCWs who were included in the analysis [median age of 47 (IQR: 36, 56) years, 66.7 % women], 13 % and 87 % had received 2 or 3 vaccine doses (full and booster vaccination), respectively. A COVID-19 infection had occurred in 135 of 1,305 of participants prior to Omicron predominance. Of those 135 HCWs with hybrid immunity only 13 (9.6 %) were re-infected. Of the 154 and 1,016 HCWs with full and booster vaccination-induced immunity, respectively, 71 (46.1 %, infection rate 13.4/100 person-months) and 448 (44.1 %, infection rate 12.2/100 person-months) were infected during the follow up period. No association between gender or age and COVID-19 infection was found and none of the participants had a severe infection or died. CONCLUSIONS: Hybrid immunity confers higher protection by almost 5-fold compared to full or booster vaccination for COVID-19 infection with the Omicron variant among HCWs who are at high risk of exposure. This may inform public health policies on how to achieve optimal immunity in terms of the timing and mode of vaccination.
引用
- Ntziora F, Kostaki EG, Karapanou A, et al. Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers. Vaccine. 2022. PMID: 36150972. doi:10.1016/j.vaccine.2022.09.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。